Abstract：Objective To develop a set of quality indicators for patients treated in Chinese hospitals to evaluate the quality of colorectal cancer care in China, which could provide reference for improving the clinical treatments of colorectal cancer, eventually enhance the quality of colorectal cancer care. Methods A framework is designed to evaluate colorectal cancer care , basing on the framework of structure, process and outcome. Collecting candidate quality indicators by searching related literatures, further refering to the American NCCN guidline and the rules of diagnosis and treatment of colorectal cancer care in China. Inviting experts to join the consult panel. Using 3-step modified Delphi approach to collect experts′views, consulting panel members were asked to score the indicators. Applying SAS 9.1.3 to calculate the average, coefficient of variation and agreement rate of indicators. Inclusion criteria: mean≥4, CV≤0.25, p≥81.25%. Results According the traits of colorectal cancer, five domains of new framework were developed,including structure, process, communicating and advising, symptoms and side-effects management, outcome. 16 experts were invited to join the panel ,all the advisory tables were regained, the response rate was 100%. 26 out of 98 candidate indicators were selected and modified after three rounds. There are 1 structure indicator, 20 process indicators, 1 communicating and advising-related indicator, 4 outcome indicators. Conclusion The developed quality indicators of colorectal cancer care conforms to Chinese national conditions, the multidimensional quality indicators can be used to comprehensively evaluate the quality of colorectal caner care , which committing to the enhancement of quality for colorectal cancer.
张慧敏， 包含， 付蓉， 刘丹， 刘美娜. 医院结直肠癌治疗质量评价指标体系的建立[J]. 中国医院统计, 2015, 22(1): 1-4.
Zhang Huimin, Bao Han, Fu Rong, Liu Dan, Liu Meina. Development of quality indicators for colorectal cancer care in Chinese hospital. journal1, 2015, 22(1): 1-4.
[1] 张渊智,李世荣,盛剑秋,等.594例原发性结直肠癌患者的临床流行病学研究[J].胃肠病学和肝病学杂志,2010,19(2):103-107. [2] Blumenthal D. Part 1: Quality of care-what is it[J]. N Engl J Med,1996,335(12):891-894. [3] Malin JL, Asch SM, Kerr EA,et al. Evaluating the quality of cancer care: development of cancer quality indicators for a global quality assessment tool[J]. Cancer, 2000,88(3):701-707. [4] Donabedian A. The quality of care. How can it be assessed[J]. JAMA,1988,260(12):1743-1748. [5] Gagliardi A R, Fung M F, Langer B, et al. Development of ovarian cancer surgery quality indicators using a modified Delphi approach[J]. Gynecol Oncol, 2005,97(2):446-456. [6] 平卫伟,谭红专.Delphi法的研究进展及其在医学中的应用[J].疾病控制杂志,2003,7(3):243-246. [7] Verrill C, Carr NJ, Wilkinson-Smith E, et al. Histopathological assessment of lymph nodes in colorectal carcinoma:does triple levelling detect significantly more metastases[J]. Journal of Clinical Pathology, 2004,57(11):1165-1167. [8] Brown B. Delphi Process: a Methodology Using for the Elicitation of Opinions of Experts[R]. The Rand Corporation,1987. [9] Cath Taylor, Louise Atkins, Alison Richardson, et al. Measuring the quality of MDT working: an observational approach[J]. BMC Cancer, 2012,(12):202-211.
